Enveric Biosciences Announces New U.S. Patents Supporting EVM301 Series and EVM201 Series Compounds [Yahoo! Finance]
Enveric Biosciences Announces New U.S. Patents Supporting EVM301 Series and EVM201 Series Compounds
Enveric Biosciences Preclinical Pharmacokinetic Studies of EB-003 Support Oral Bioavailability, Demonstrate Brain Penetration, and Show No Evidence of Hallucination-like Behavior [Yahoo! Finance]
Enveric Biosciences Preclinical Pharmacokinetic Studies of EB-003 Support Oral Bioavailability, Demonstrate Brain Penetration, and Show No Evidence of Hallucination-like Behavior
Enveric Biosciences Reports Third Quarter 2024 Financial and Corporate Results [Yahoo! Finance]